Greater Cannabis Stock Performance
| GCAN Stock | USD 0.0005 0.00 0.00% |
Greater Cannabis holds a performance score of 5 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 3.79, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Greater Cannabis will likely underperform. Use Greater Cannabis information ratio and the relationship between the treynor ratio and kurtosis , to analyze future returns on Greater Cannabis.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Greater Cannabis are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Greater Cannabis displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 113 K |
Greater |
Greater Cannabis Relative Risk vs. Return Landscape
If you would invest 0.05 in Greater Cannabis on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Greater Cannabis or generate 0.0% return on investment over 90 days. Greater Cannabis is currently generating 1.0355% in daily expected returns and assumes 14.6647% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Greater, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Greater Cannabis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Greater Cannabis' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Greater Cannabis, and traders can use it to determine the average amount a Greater Cannabis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0706
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GCAN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.66 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.04 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Greater Cannabis is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Greater Cannabis by adding it to a well-diversified portfolio.
Greater Cannabis Fundamentals Growth
Greater Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Greater Cannabis, and Greater Cannabis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Greater Pink Sheet performance.
| Return On Asset | -0.39 | |||
| Current Valuation | 688.64 K | |||
| Shares Outstanding | 668.64 M | |||
| Price To Earning | 3.90 X | |||
| Price To Sales | 50.70 X | |||
| Revenue | 12.63 K | |||
| EBITDA | (310.21 K) | |||
| Cash And Equivalents | 311.2 K | |||
| Total Debt | 702.44 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (235.43 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 392.94 K | |||
About Greater Cannabis Performance
By examining Greater Cannabis' fundamental ratios, stakeholders can obtain critical insights into Greater Cannabis' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Greater Cannabis is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. The company was founded in 2014 and is based in Baltimore, Maryland. Greater Cannabis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Greater Cannabis performance evaluation
Checking the ongoing alerts about Greater Cannabis for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Greater Cannabis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Greater Cannabis is way too risky over 90 days horizon | |
| Greater Cannabis has some characteristics of a very speculative penny stock | |
| Greater Cannabis appears to be risky and price may revert if volatility continues | |
| Greater Cannabis has high likelihood to experience some financial distress in the next 2 years | |
| Greater Cannabis currently holds 702.44 K in liabilities. Greater Cannabis has a current ratio of 0.31, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Greater Cannabis until it has trouble settling it off, either with new capital or with free cash flow. So, Greater Cannabis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Greater Cannabis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Greater to invest in growth at high rates of return. When we think about Greater Cannabis' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 12.63 K. Net Loss for the year was (602.23 K) with loss before overhead, payroll, taxes, and interest of (5.03 K). | |
| Greater Cannabis currently holds about 311.2 K in cash with (235.43 K) of positive cash flow from operations. | |
| Roughly 68.0% of the company shares are held by company insiders |
- Analyzing Greater Cannabis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Greater Cannabis' stock is overvalued or undervalued compared to its peers.
- Examining Greater Cannabis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Greater Cannabis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Greater Cannabis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Greater Cannabis' pink sheet. These opinions can provide insight into Greater Cannabis' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Greater Pink Sheet
Greater Cannabis financial ratios help investors to determine whether Greater Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Greater with respect to the benefits of owning Greater Cannabis security.